Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Boehringer Ingelheim
Farmers Insurance

Generated: March 21, 2018

DrugPatentWatch Database Preview

Details for Patent: 7,342,005

« Back to Dashboard

Summary for Patent: 7,342,005
Title:Antibiotic compounds
Abstract:The present invention relates to carbapenems and provides a compound of the formula (I): ##STR00001## or a pharmaceutically acceptable salt or in vivo hydrolysable ester thereof wherein: R.sup.1 is 1-hydroxyethyl, 1-fluoroethyl or hydroxymethyl; R.sup.2 is hydrogen or C.sub.1-4alkyl; R.sup.3 is hydrogen or C.sub.1-4alkyl; R.sup.4 and R.sup.5 are the same or different and are selected from hydrogen, halo, cyano, C.sub.1-4alkyl, nitro, hydroxy, carboxy, C.sub.1-4alkoxy, C.sub.1-4alkoxycarbonyl, aminosulphonyl, C.sub.1-4alkylaminosulphonyl, di-C.sub.1-4-alkylaminosulphonyl, carbamoyl, C.sub.1-4alkylcarbamoyl, di-C.sub.1-4alkylcarbamoyl, trifluoromethyl, sulphonic acid, amino, C.sub.1-4alkylamino, di-C.sub.1-4alkylamino, C.sub.1-4alkanoylamino, C.sub.1-4alkanoyl(N--C.sub.1-4alkyl)amino, C.sub.1-4alkanesulphonamido and C.sub.1-4alkylS(O).sub.n--wherein n is zero, one or two; with the proviso that there is no hydroxy or carboxy substituent in a position ortho to the link to --NR.sup.3--; processes for their preparation, intermediates in their preparation, their use as therapeutic agents and pharmaceutical compositions containing them.
Inventor(s): Betts; Michael John (Wilmslow, GB), Davies; Gareth Morse (Macclesfield, GB), Swain; Michael Lingard (Stockport, GB)
Assignee: AstraZeneca UK Limited (London, GB)
Application Number:11/126,331
Patent Claim Types:
see list of patent claims
Composition; Formulation; Compound; Process;

Drugs Protected by US Patent 7,342,005

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 7,342,005

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom9202298.7Feb 04, 1992

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Argus Health
Federal Trade Commission
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.